KDM5B and hepatocellular carcinoma: In order to test the oncogenic activity of JARID1B in HCC, we retrovirally established stable overexpression of JARID1B in Huh7 and HepG2 cells, and silencing of JARID1B in SNU423 and SK-Hep1 cells.